[Urogenital tuberculosis. Apropos of 40 cases].
The authors report a series of 40 cases of genitourinary tuberculosis diagnosed and treated in the department of urology "B" of Avicenne hospital over a 7-year period. The objective of this study is to define the various diagnostic and therapeutic aspects of this disease. The patients were predominantly males (62.5%) with a mean age of 40 years. 25% of cases reported a history of extra-urinary tuberculosis. The very polymorphous clinical presentation is dominated by signs of cystitis (45%). Intravenous urography is frequently suggestive of the diagnosis based on the appearance and multiplicity of the lesions. The radiological lesions most frequently encountered were silent kidney (19 cases) and small tuberculous bladder (11 cases). The definitive diagnosis was established by pathological examination in 38 cases (biopsies, operative specimens, prostatic resection chips) and/or by demonstration of AFB in 2 cases (urine, pus). Tuberculostatic treatment was administered to all patients, either alone (5 cases) or, more usually, in combination with surgical and/or endo-urological treatment (35 cases), reflecting the magnitude and severity of the destructive and scar lesions.
el Khader
K
K
Service d'Urologie' B, Hôpital Avicenne, Rabat, Maroc.
el Fassi
J
J
Karmouni
T
T
Tazi
K
K
Ibnattya
A
A
Hachimi
M
M
Lakrissa
A
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D001706:Biopsy; D003131:Combined Modality Therapy; D003251:Constriction, Pathologic / Q000628:therapy; D003556:Cystitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology / Q000601:surgery; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D009392:Nephrectomy; D011469:Prostatic Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology / Q000601:surgery; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D015607:Stents; D014389:Tuberculosis, Male Genital / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery; D014398:Tuberculosis, Renal / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery; D014399:Tuberculosis, Spinal / Q000150:complications; D014401:Tuberculosis, Urogenital / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery; D014515:Ureteral Diseases / Q000628:therapy; D001745:Urinary Bladder Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology / Q000601:surgery; D014567:Urography
D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin
La tuberculose uro-génitale. A propos de 40 cas.